Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Revenues:    
Product Revenue $ 302,475 $ 643,187
Product Revenue - Related party 24,063
Total Revenues 302,475 667,250
Cost of Sales:    
Product Cost of Sales (297,500) (258,721)
Gross Income 4,975 408,529
Administrative Expenses 915,533 790,529
Sales and Marketing Expenses 468,463 556,655
Sales and Marketing Expenses - Related Party 31,689 32,279
Research and Development Expenses 391,381 348,442
Research and Development Expenses - Related Party 48,589
Amortization of Non-Current Assets 42,777 42,777
Loss from Operations (1,893,457) (1,362,153)
Other (Income)/Expenses    
Foreign Currency Transaction (Gain)/Loss 2,875 (10,346)
Interest and Dividend Income (36,341) (2,537)
Total Other Income (33,466) (12,883)
Loss Before Income Taxes (1,859,991) (1,349,270)
Income Tax Benefit
Net Loss Attributable to Common Shareholders (1,859,991) (1,349,270)
Other Comprehensive Income/(Loss)    
Net Unrealized Gain/(Loss) on Marketable Securities (16,843) 156
Total Other Comprehensive Income/(Loss) (16,843) 156
Comprehensive Loss $ (1,876,834) $ (1,349,114)
Basic and Diluted loss per common share $ (0.03) $ (0.19)
Weighted average basic and diluted common shares outstanding 71,315,461 6,993,574